• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Liam Dwyer, England

    Liam Dwyer, England

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Mike Cels, Canada

    Mike Cels, Canada

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • David Solomon, UK

    David Solomon, UK

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Greg Heydet, USA

    Greg Heydet, USA

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Glen Elison, USA

    Glen Elison, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Sally Pauls, USA

    Sally Pauls, USA

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Denis Blais, Canada

    Denis Blais, Canada

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Frank Taylor, USA

    Frank Taylor, USA

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Hollister

    Hollister
    hollister

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • David Bishop, UK

    David Bishop, UK

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login